Ming Liang Li
Presidente presso IBT II Venture Capital Co., Ltd.
Profilo
Dr. Ming Liang Li is Chairman at Boston Life Science Venture Co. and Chairman at IBT II Venture Capital Co., Ltd.
He is on the Board of Directors at Reber Genetics Co., Ltd., Taiwan Research-based Biopharmaceutical Manufacturers Assoc, Taiwan Global BioFund, and Industrial Bank of Taiwan Co. Ltd.
/Private Group/.
Dr. Li was previously employed as Independent Director by China Bills Finance Corp.
and a Professor by Tzu Chi University.
He received his doctorate degree from Miami University (Ohio).
Posizioni attive di Ming Liang Li
Società | Posizione | Inizio |
---|---|---|
IBT II Venture Capital Co., Ltd.
IBT II Venture Capital Co., Ltd. Investment ManagersFinance IBT II Venture Capital Co. Ltd. invests in companies located in Taiwan, the US, China, South East Asia, and Europe. The fund targets companies operating in the fields of consumer electronics, communications, semiconductors, optoelectronics, networking, computers, biotechnology, pharmaceuticals, healthcare services, green energy and environmental services. It provides financing for expansion, early and later stage capital requirements. | Presidente | - |
Taiwan Research-based Biopharmaceutical Manufacturers Assoc | Direttore/Membro del Consiglio | - |
Taiwan Global BioFund
Taiwan Global BioFund Investment ManagersFinance Taiwan Global BioFund invests exclusively in life science companies located in Taiwan and US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals, diagnostics, medical devices, medical services, and medical informatics. It provides financing for seed, early and later stage capital requirements. | Direttore/Membro del Consiglio | - |
Industrial Bank of Taiwan Co. Ltd. /Private Group/
Industrial Bank of Taiwan Co. Ltd. /Private Group/ Financial ConglomeratesFinance Industrial Bank of Taiwan Co. Ltd. is led by a private group. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Ming Liang Li
Società | Posizione | Fine |
---|---|---|
CHINA BILLS FINANCE CORPORATION | Direttore/Membro del Consiglio | 19/06/2012 |
REBER GENETICS CO LTD | Direttore/Membro del Consiglio | - |
Boston Life Science Venture Co.
Boston Life Science Venture Co. Investment ManagersFinance Boston Life Science Venture Co. is a venture capital fund. The company is based in Taipei, Taiwan. | Presidente | - |
Tzu Chi University | Corporate Officer/Principal | - |
Formazione di Ming Liang Li
Miami University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CHINA BILLS FINANCE CORPORATION | Finance |
Aziende private | 6 |
---|---|
Boston Life Science Venture Co.
Boston Life Science Venture Co. Investment ManagersFinance Boston Life Science Venture Co. is a venture capital fund. The company is based in Taipei, Taiwan. | Finance |
Reber Genetics Co., Ltd.
Reber Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Reber Genetics Co., Ltd. engages in the research, development, production, and sale of animal vaccines. Its products include PRRS and PCV2 subunit vaccines. The company was founded on April 18, 2008 and is headquartered in Taipei, Taiwan. | Health Technology |
IBT II Venture Capital Co., Ltd.
IBT II Venture Capital Co., Ltd. Investment ManagersFinance IBT II Venture Capital Co. Ltd. invests in companies located in Taiwan, the US, China, South East Asia, and Europe. The fund targets companies operating in the fields of consumer electronics, communications, semiconductors, optoelectronics, networking, computers, biotechnology, pharmaceuticals, healthcare services, green energy and environmental services. It provides financing for expansion, early and later stage capital requirements. | Finance |
Taiwan Research-based Biopharmaceutical Manufacturers Assoc | |
Taiwan Global BioFund
Taiwan Global BioFund Investment ManagersFinance Taiwan Global BioFund invests exclusively in life science companies located in Taiwan and US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals, diagnostics, medical devices, medical services, and medical informatics. It provides financing for seed, early and later stage capital requirements. | Finance |
Industrial Bank of Taiwan Co. Ltd. /Private Group/
Industrial Bank of Taiwan Co. Ltd. /Private Group/ Financial ConglomeratesFinance Industrial Bank of Taiwan Co. Ltd. is led by a private group. | Finance |
- Borsa valori
- Insiders
- Ming Liang Li